PT Jayamas Medica Industri Tbk (IDX:OMED)

IDX:OMED Income Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,894,749	1,885,822	1,736,990	1,739,054	2,226,573	1,994,540
Revenue Growth (YoY)	7.20%	8.57%	-0.12%	-21.89%	11.63%	62.41%
Cost of Revenue	1,262,592	1,261,846	1,184,990	1,176,045	1,322,544	957,599
Gross Profit	632,157	623,976	552,000	563,010	904,030	1,036,940
Selling, General & Admin	295,161	275,502	250,002	198,309	168,243	186,715
Other Operating Expenses	-2,246	3,016	1,842	-7,542	2,951	736.38
Operating Expenses	292,990	278,518	251,843	190,767	171,194	187,451
Operating Income	339,167	345,458	300,156	372,243	732,836	849,489
Interest Expense	-19,634	-19,768	-19,581	-20,805	-21,840	-9,008
Interest & Investment Income	62,408	57,008	43,520	14,371	16,909	14,945
Currency Exchange Gain (Loss)	23,830	11,911	1,654	6,704	1,445	5,821
Other Non Operating Income (Expenses)	-471.82	-460.86	-341.03	-403.98	-328.64	-149.77
EBT Excluding Unusual Items	405,298	394,148	325,409	372,109	729,020	861,098
Gain (Loss) on Sale of Assets	-362.56	-121.48	35.59	0.04	179.92	583.7
Pretax Income	404,936	394,026	325,444	372,109	729,200	861,681
Income Tax Expense	71,978	70,074	64,462	81,602	158,821	168,812
Earnings From Continuing Operations	332,957	323,952	260,982	290,507	570,379	692,869
Minority Interest in Earnings	-1,981	-2,279	-1,622	-4,725	-7,687	-7,359
Net Income	330,977	321,673	259,360	285,782	562,692	685,510
Net Income to Common	330,977	321,673	259,360	285,782	562,692	685,510
Net Income Growth	24.24%	24.03%	-9.25%	-49.21%	-17.92%	203.04%
Shares Outstanding (Basic)	27,059	27,059	27,059	27,059	27,059	27,455
Shares Outstanding (Diluted)	27,059	27,059	27,059	27,059	27,059	27,455
Shares Change (YoY)	-	-	-	-	-1.44%	-46.28%
EPS (Basic)	12.23	11.89	9.59	10.56	20.80	24.97
EPS (Diluted)	12.23	11.89	9.59	10.56	20.80	24.97
EPS Growth	24.24%	24.03%	-9.25%	-49.21%	-16.71%	464.16%
Free Cash Flow	312,546	249,245	-22,031	17,549	422,386	228,771
Free Cash Flow Per Share	11.55	9.21	-0.81	0.65	15.61	8.33
Dividend Per Share	-	-	6.050	-	10.870	17.000
Dividend Growth	-	-	-	-	-36.06%	-
Gross Margin	33.36%	33.09%	31.78%	32.37%	40.60%	51.99%
Operating Margin	17.90%	18.32%	17.28%	21.40%	32.91%	42.59%
Profit Margin	17.47%	17.06%	14.93%	16.43%	25.27%	34.37%
Free Cash Flow Margin	16.50%	13.22%	-1.27%	1.01%	18.97%	11.47%
EBITDA	384,015	388,670	334,660	392,559	752,142	864,958
EBITDA Margin	20.27%	20.61%	19.27%	22.57%	33.78%	43.37%
D&A For EBITDA	44,849	43,213	34,504	20,317	19,307	15,469
EBIT	339,167	345,458	300,156	372,243	732,836	849,489
EBIT Margin	17.90%	18.32%	17.28%	21.40%	32.91%	42.59%
Effective Tax Rate	17.77%	17.78%	19.81%	21.93%	21.78%	19.59%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.